Brief: Argent Biopharma Ltd Says Ordinary Shares Approved To Trade On The Otcqb Venture Market In The United States
07/05/2024 02:18
May 7 (Reuters) - Argent BioPharma Ltd RGT.AX :
* ORDINARY SHARES APPROVED TO TRADE ON THE OTCQB VENTURE
MARKET
IN THE UNITED STATES
* SHARES COMMENCED TRADING AT THE MARKET OPEN ON 2 MAY 2024
Further company coverage: RGT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement
Brief: Argent Biopharma Secures A$11M Financing Facility To Complete Strategic Acquisition
Brief: Argent Is Growing Through M&A Projected Merged Company Value Of $100M In Ac8 Asset Acquisition
Australia's Argent BioPharma set for best day in a year on AusCann deal
Brief: Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group